HKD 3.58
(-0.56%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 8.84 Million USD | -17.77% |
2022 | 10.75 Million USD | 52.78% |
2021 | 7.04 Million USD | 144.36% |
2020 | 2.88 Million USD | 45.14% |
2019 | 1.98 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 421 Thousand USD | 1951.31% |
2024 Q1 | 421 Thousand USD | -95.24% |
2023 FY | 8.84 Million USD | -17.77% |
2023 Q2 | 10.07 Million USD | -73.12% |
2023 Q1 | 37.49 Million USD | 248.57% |
2023 Q4 | 8.84 Million USD | -76.92% |
2023 Q3 | 38.31 Million USD | 280.17% |
2022 Q2 | 8.74 Million USD | -64.15% |
2022 Q1 | 24.38 Million USD | 246.36% |
2022 FY | 10.75 Million USD | 52.78% |
2022 Q4 | 10.75 Million USD | -71.8% |
2022 Q3 | 38.14 Million USD | 336.33% |
2021 Q3 | 4.82 Million USD | 0.0% |
2021 FY | 7.04 Million USD | 144.36% |
2021 Q4 | 7.04 Million USD | 46.0% |
2021 Q1 | - USD | -100.0% |
2020 Q4 | 2.88 Million USD | 0.0% |
2020 FY | 2.88 Million USD | 45.14% |
2019 FY | 1.98 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | 83.269% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 99.851% |